Amicus Therapeutics Inc (NASDAQ:FOLD)
| 2.51 Data as of 1:56pm ET |  -0.005 / -0.20%Today’s Change | 2.30 Today|||52-Week Range 6.89 | -6.34% Year-to-Date |
Latest FOLD News | Press Releases
| Market Wrap for Tuesday, June 17: Stocks Jump to Start Trading Week; Dow Rallies Trip... Jun 17 / Benzinga | Amicus Delays U.S. Approval Filing for Fabry Disease Drug Jun 17 / TheStreet.com |
| Afternoon Market Losers Jun 17 / Benzinga | Amicus Therapeutics to Discuss Regulatory Strategy on 8:00 AM ET Conference Call Jun 17 / Benzinga |
| Morning Market Losers Jun 17 / Benzinga |
Today’s Trading
| Previous close | 2.52 |
| Today’s open | 2.49 |
| Day’s range | 2.43 - 2.54 |
| Volume | 309,266 |
| Average volume (3 months) | 415,274 |
| Market cap | $124.8M |
| Dividend yield | -- |
Data as of 1:56pm ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | +16.41% |
| Earnings growth (this year) | -32.18% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -14.10% |
| P/E ratio | NM |
| Price/Sales | 6.63 |
| Price/Book | 1.80 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AMBIAmbit Biosciences Co... | +0.18 | +2.52% |
| KBIOKaloBios Pharmaceuti... | -0.06 | -1.18% |
| MEIPMEI Pharma Inc | +0.21 | +2.82% |
| APPAA.P. Pharma Inc | -0.03 | -6.59% |
Data as of 1:55pm ET, 06/19/2013
Financials
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | -$0.35 |
| Annual revenue (last year) | $18.4M |
| Annual profit (last year) | -$48.8M |
| Net profit margin | -264.98% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer John F. Crowley, MBA |
Chief Financial Officer William D. Baird, III, MBA |
Corporate headquarters Cranbury, New Jersey |
Forecasts
